Digital Health Global Market Report 2023 – By Technology (Mobile Health (mhealth), Health Information Technology, Telehealth And Telemedicine, Health Analytics, Other Technologies), By Application (Cardiology, Diabetes, Neurology, Sleep Apnea, Oncology, Other Applications), By End User (Healthcare Providers, Healthcare Payers, Pharmaceutical Companies, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Business analytics (BA) is a set of technologies, skills, and practices used to examine an organization's data and performance to better understand and make data-driven decisions in the future using statistical analyses. Enterprise software is a computer application that assists large companies with many needs such as data analysis, sales and marketing management, customer service and many more. These tools are designed to serve many users with high scalability and integration. The main types of business analytics & enterprise software are ERP software, BI software, CRM software, SCM software and other software. ERP software is a software that is used by organizations to manage and plan daily activities of a business such as finance, manufacturing, supply chain, human resources and others. They are deployed using models such as on-demand/cloud model and on-premise model and are used in IT and telecommunications, BFSI, manufacturing, retail, healthcare, education, media and other end use industries. The global business analytics and enterprise software market is segmented - 1) By Type: ERP Software, BI Software, CRM Software, SCM Software, Other Software 2) By End-User Industry: IT and Telecommunications, BFSI, Manufacturing, Retail, Healthcare, Education, Media, Other End-User Industries 3) By Deployment Model: On-Demand/Cloud, On-Premise The global business analytics & enterprise software market size grew from $423.18 billion in 2022 to $486.54 billion in 2023 at a compound annual growth rate (CAGR) of 15.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The business analytics & enterprise software market is expected to grow to $837.88 billion in 2027 at a CAGR of 14.6%. Mobility is an integrated component of digital solutions and is transforming businesses on a global scale driving demand for IT services. It is an essential feature for customer experience management and for enhancing interaction amongst strategic partners and suppliers. It also provides greater access to information and services which can be integrated to execute critical business operations. The development and implementation of mobile applications requires IT services. For example, Tieto's competitive asset in mobility and Tieto's enterprise mobility solution framework offers customized solutions to companies operating in healthcare, logistics, telecommunications, energy and manufacturing verticals. Major companies in the business analytics & enterprise software market include Oracle Corp, salesforce.com, Microsoft, Fiserv, Inc., Nippon Telegraph And Telephone Corp, NTT Data, International Business Machines Corporation, Workday, Inc., Leidos (US) and Atos SE. The outbreak of COVID-19 disease (COVID-19) has acted as a significant restraint on the business analytics & enterprise software market in 2020 as supply chains were disrupted due to trade restrictions and employees working for these establishments faced difficulties related to infrastructure and communication owing to lockdowns imposed by governments globally, forcing them to work from home. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People's Republic of China and spread globally including Western Europe, North America and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of 'lock down' and the outbreak had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the business analytics & enterprise software market will recover from the shock across the forecast period as it is a 'black swan' event and not related to ongoing or fundamental weaknesses in the market or the global economy. Over the past five years there has been an increasing prevalence of low cost open source alternatives. Open source has become a preferred platform for developing new technology. In the past, software product companies would open source software that was not making money, but now companies are open sourcing software to increase its presence and share in the market. According to Allison Randal, President, Open Source Initiative, 78% of companies use open source solutions and 64% participate in open source projects indicating an increase in open source software platforms to build applications. In April 2021, International Business Machines Corporation (IBM), a US-based technology company announced the acquisition of Turbonomic, for $2 billion. This deal will help IBM to provide companies with solutions to overcome the high costs associated with managing performance and availability for multiple applications sharing an increasingly complex hybrid cloud environment. Turbonomic is a US-based enterprise software company. Asia-Pacific was the largest region in business analytics & enterprise software market in 2022. North America was the second largest region in business analytics & enterprise software industry. The regions covered in the business analytics & enterprise software market analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the business analytics & enterprise software market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The business analytics & enterprise software market includes revenues earned by entities by developing and distributing software that are used to analyze business data to better understand an organization's strengths and weaknesses. Enterprise software is a software used to satisfy the needs of an organization rather than individual users. Such organizations include businesses, schools, interest-based user groups, clubs, charities, and governments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The business analytics & enterprise software market research report is one of a series of new reports from The Business Research Company that provides business analytics & enterprise software market statistics, including business analytics & enterprise software market size, regional shares, competitors with a business analytics & enterprise software market share, detailed business analytics & enterprise software market segments, business analytics and enterprise software market trends and opportunities, business analytics and enterprise software market growth and any further data you may need to thrive in the business analytics & enterprise software industry. This business analytics & enterprise software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pharmacies and healthcare stores are stores that sell pharmaceuticals and healthcare products such as drugs, medical devices, and other personal care products. The main types of pharmacies and healthcare stores are pharmacies, drug stores, and other health and personal care stores. A pharmacy is a venue where one can purchase prescription drugs within a chemist's or drugstore, or in a supermarket or other stores. The forms of ownership are retail chains and independent retailers, selling types of drugs that include prescription drugs, over the counter (otc) drugs, and other drug types. The global pharmacies and healthcare stores market is segmented - 1) By Type: Pharmacies and Drug Stores, Other Health and Personal Care Stores 2) By Ownership: Retail Chain, Independent Retailer 3) By Drug Type: Prescription Drugs, Over-the-Counter (OTC) Drugs, Other Drug Types The global pharmacies and healthcare stores market size will grow from $1,192.37 billion in 2022 to $1,274.74 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pharmacies and healthcare stores market is expected to grow to $1,593.34 billion in 2027 at a CAGR of 5.7%. The pharmacy and healthcare store market is expected to benefit from steady economic growth forecasted for many developed and developing countries. According to International Monetary Fund (IMF), the global GDP growth was 3.3% in 2020 and 3.4% in 2021. Recovering commodity prices, after a decline in the historic period is further expected to be a significant factor driving economic growth. The US economy is expected to register stable growth during the forecast period. Additionally, emerging markets are expected to continue to grow slightly faster than developed markets in the forecast period. Greater economic growth is likely to drive public and private investments, joint ventures, and foreign direct investments in the end-user markets, thereby driving the market during the forecast period. Major companies in the pharmacies and healthcare stores market include CVS Health Corporation, McKesson Corporation, Walgreens Boots Alliance Inc., Rite Aid Corp, Costco Wholesale Corp, Loblaw, George Weston Ltd., TSURUHA Holdings Inc., COSMOS Pharmaceutical Corporation, and Welcia Holdings Co. Ltd. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the pharmacies and healthcare store market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in the manufacture and trade of non-essential goods and an overall decline in economic activity with countries entering a state of "lock down" and the outbreak having a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the pharmacies and healthcare stores market will recover from the shock over the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. Pharmacies are increasingly using medicine vending machines to service customers, especially in remote locations where they cannot invest in opening an establishment and stationing pharmacists. The medicine vending machine is equipped with a phone, an internet connection, a prescription scanner, an in-built POS machine, and up to 2,000 packs of commonly used prescription drugs. The machine identifies drugs with the help of a microchip attached to the packs. The vending machine also allows patients to speak with a pharmacist via video link. The pharmacist checks the prescription and authorises the transaction, and then the patient can pay either by inserting cash into the machine or through a debit or credit card. Once the payment is confirmed, the medicine can be collected from the dropbox of the machine. For instance, PharmaTrust, a Canadian company, has developed vending machines and has installed them in the UK. Patients go up to the PharmaTrust kiosk, insert their prescription, scan their health card, then pick up the phone and talk personally to an on-call pharmacist. The pharmacist determines if the medication is appropriate and then authorises the transaction. Arizona State University and Florida State University installed pharmaceutical vending machines to dispense a wide range of drugs in their Student Health Services buildings. North America was the largest region in the pharmacies and healthcare stores market in 2022. Western Europe was the second-largest region in the pharmacies and healthcare stores market. The regions covered in the pharmacies and healthcare stores market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the pharmacies and healthcare stores market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The pharmacies and healthcare store market includes revenues earned by entities by providing services through hospital pharmacies, online pharmacies, and specialty stores. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pharmacies and healthcare stores market research report is one of a series of new reports from The Business Research Company that provides pharmacies and healthcare store market statistics, including pharmacies and healthcare store industry global market size, regional shares, competitors with a pharmacies and healthcare store market share, detailed pharmacies and healthcare store market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacies and healthcare store industry. This pharmacies and healthcare stores market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Point-of-care diagnostics devices are designed to aid doctors in performing medical diagnostic testing at or near the point of care, for immediate knowledge on diseases or conditions. These devices are used to test glucose and cholesterol levels, do electrolyte and enzyme analysis, test for drugs of abuse and for infectious diseases, and for pregnancy testing. The main types of point-of-care diagnostic devices and equipment are infectious disease testing kits, cardiometabolic monitoring kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, and others. Pregnancy and fertility test kits are point-of-care diagnostic devices used to test pregnancy and fertility prior to seeing a doctor. The various prescription modes include prescription-based testing devices, and over-the-counter (OTC) testing devices. These are used by end-users such as professional diagnostic centers, hospitals/critical care centres, outpatient healthcare settings, ambulatory care settings, research laboratories, and homes. The global point-of-care diagnostics devices and equipment market is segmented - 1) By Type: Infectious disease testing kits, Cardio metabolic monitoring kits,, Cholesterol testing kits, Pregnancy and fertility tests kits, Tumor/Cancer markers, Urinalysis testing kits, Hematology testing kits, Drugs of abuse testing kits, Fecal occult testing kits, Other Types 2) By End User: Professional diagnostic centers, Hospitals/critical care centers, Outpatient healthcare Setting, Ambulatory care settings, Research laboratories, Home 3) By Prescription Mode: Prescription-based Testing Devices, Over-The-Counter (OTC) Testing Devices The global point-of-care diagnostics devices and equipment market size will grow from $28.47 billion in 2022 to $32.34 billion in 2023 at a compound annual growth rate (CAGR) of 13.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global point-of-care diagnostics devices and equipment is expected to grow to $48.35 billion in 2027 at a CAGR of 10.6%. An increase in the incidence of target diseases is driving the POC devices and equipment market globally. The rising incidence of chronic diseases, like diabetes, rheumatism, or cancer is increasing steadily worldwide due to poor lifestyle choices and increasing obesity, thus driving the growth of the POC devices and equipment market. For example, according to the Centers for Disease Control and Prevention, In 2020, about 697,000 people in the US died due to heart disease. Major players in the point-of-care diagnostic devices and equipment market report are Abbott, F. Hoffmann-La Roche, Siemens Healthineers, Danaher, Beckman Coulter, Becton Dickinson and Company, QIAGEN N.V., Johnson & Johnson, Alere Inc., and BioMerieux. The POC diagnostics devices and equipment market is expected to slow down due to stringent regulatory policies, which increase the gestational period before the product enters the market. POC devices and equipment manufacturers are required to obtain multiple FDA clearances before launching their product into the market. The entire process of approval consumes a lot of time, thereby restraining the point-of-care diagnostic devices and equipment market growth. Over-the-Counter (OTC) testing is being termed as an important trend driving the growth of the point of care diagnostics market. FDA has approved OTC test kits for cholesterol, fecal occult blood, pregnancy, and HIV/HCV. This method would improve the access to testing and early detection of the disease. These testing kits may generate more revenue than prescription tests over the forecast period due to ease of using the kits, increased home care and self-testing, and a rise in availability and adoption rate. Point of care devices is regulated by the U.S. Food and Drug Administration (FDA) and all the diagnostic laboratory tests are regulated by the clinical laboratory improvement amendments of 1988 (CLIA) that are administered by the Centers for Medicare & Medicaid Services (CMS). As these devices measure the biomarker levels in the body they are classified as class II (requiring 510[k] approval), or III devices (requiring the more tedious premarket approval). On the contrary, to the stringent approvals by FDA, China has a moderately lenient approval mechanism. Therefore, the top companies are using a partnership approach with local vendors and distributors to expand their point-of-care diagnostic devices and equipment market share. North America was the largest region in the point-of-care diagnostic devices and equipment market in 2022. Asia-Pacific was the second-largest region in the global point-of-care diagnostics devices and equipment market share. The regions covered in point-of-care diagnostics devices and equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the point-of-care diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The point-of-care diagnostics market consists of sales of instruments such as pregnancy and fertility testing kits, cholesterol test strips, drug abuse testing kits, and others that are used in point-of-care diagnostics. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The point-of-care diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides point-of-care diagnostics devices and equipment market statistics, including point-of-care diagnostics devices and equipment industry global market size, regional shares, competitors with a point-of-care diagnostics devices and equipment market share, detailed point-of-care diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care diagnostics devices and equipment industry. This point-of-care diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Defibrillator devices and equipment are used in the emergency treatment of life-threatening cardiac arrhythmias and abnormal heart rhythms by giving a high-energy electrical shock to the heart through the chest wall to restore its normal rhythm function. The main types of defibrillator devices and equipment are implantable defibrillators and external defibrillators. Implantable defibrillators are small, battery-powered devices placed in the body for the purpose of detecting and stopping irregular heartbeats. The implantable defibrillators are transvenous implantable cardioverter-defibrillator (T-ICDS), subcutaneous implantable cardioverter-defibrillator (S-ICDS), cardiac resynchronization therapy-defibrillator (CRT-D), single & dual chamber. The external defibrillators are manual external defibrillators (MEDs), automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). The various end-users are hospitals, pre-hospitals, the public access market, the alternate care market, and home healthcare. The global defibrillator devices and equipment market is segmented - 1) By Type: Implantable Defibrillators, External defibrillators 2) By Implantable Defibrillators: Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), Cardiac Resynchronization Therapy- Defibrillator (CRT-D), Single & Dual Chamber 3) By External defibrillators: Manual External Defibrillator (MEDs), Automated External Defibrillator (AEDs), Wearable Cardioverter Defibrillator (WCDs) 4) By End User: Hospitals, Pre-Hospitals, Public Access Market, Alternate Care Market, Home Healthcare The global defibrillator devices and equipment market size will grow from $9.75 billion in 2022 to $10.61 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of defibrillator devices and equipment is expected to grow to $14.12 billion in 2027 at a CAGR of 7.4%. The rising incidence of sudden cardiac arrest (SCA) is one of the major drivers of the defibrillator devices and equipment market. According to the American Heart Association (AHA), the annual incidence of SCA in people of any age is around 356,461. SCA is characterized by the complete cessation of cardiac activity and defibrillators are used to deliver a therapeutic shock to the patient to revive the heartbeat. Due to this, the market for defibrillators is forecasted to grow. Major players in the defibrillator devices and equipment market are Medtronic, St. Jude Medical LLC., Boston Scientific Corporation, Koninklijke Philips N.V, ZOLL Medical Corporation, Cardiac Science, Physio-Control Inc., Nihon Kohden Corporation, Defibtech LLC., and Schiller AG. The high cost of these devices is impeding the defibrillator devices and equipment research. In the USA, the health care costs for administering therapeutic shock using implantable cardioverter-defibrillator (ICD) range between about $1,300 and $20,000 per patient for outpatient and inpatient care. Apart from healthcare costs, other charges such as maintenance cost, battery replacement cost, and annual servicing charges are also added to the overall cost. For instance, if AED (Automatic External Defibrillator) is used on a person suffering from a sudden cardiac arrest, then it will need to undergo maintenance before it can be used again. This includes service and the replacement of batteries and pads. Owing to these economic factors, the growth of the overall market for defibrillator devices and equipment is restrained. Technological advances are one of the major trends being witnessed in the defibrillator and equipment market. Over the last three decades, AEDs (Automated External Defibrillators) have been upgraded with several new features such as rechargeable batteries, LCD screens, voice prompts, CPR tutorials, sophisticated self-testing software, fully automatic operation, and new types of shocks. There have been several recent advancements in implantable cardioverter-defibrillator (ICD) technology to extend battery life, improvements in patient monitoring to avoid needless shocks, the introduction of quadripolar lead devices to improve device programming and to improve therapy effectiveness, and the development of magnetic resonance imaging (MRI)-safe ICDs. Defibrillators are subjected to stricter regulations by USFDA when compared to other devices. For instance, the US FDA ordered the PMA approval for new and existing automated external defibrillators. Due to manufacturing issues, the FDA has recalled more than 2 million devices since 2005. North America was the largest region in the global defibrillator devices and equipment market in 2022. Western Europe was the second-largest region in the defibrillator devices and equipment market report. The regions covered in the global defibrillator devices and equipment industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the defibrillator devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The defibrillator devices and equipment market consist of sales of instruments such as manual external defibrillator, implantable cardioverter defibrillator, manual internal defibrillator, automated external defibrillator, and wearable defibrillators. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The defibrillator devices and equipment market research report is one of a series of new reports from The Business Research Company that provides defibrillator devices and equipment market statistics, including defibrillator devices and equipment industry global market size, regional shares, competitors with a defibrillator devices and equipment market share, detailed defibrillator devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the defibrillator devices and equipment industry. This defibrillator devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Injectable drug delivery devices are used for various routes of drug administration such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular. The main types of injectable drug delivery devices are conventional injectable, pre-filled syringes, auto-injectors, and pen-injectors. The prefilled syringes are the packaging with the fixed needle that contains single-dose vaccines or other medications. The injectable drug delivery devices offer applications such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and others that are used by various end-users such as hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others. The global injectable drug delivery devices market is segmented - 1) By Type: Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors 2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications 3) By End Users: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users The global injectable drug delivery devices market size will grow from $39.93 billion in 2022 to $43.54 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global injectable drug delivery devices is expected to grow from $58.1 billion in 2027 at a CAGR of 7.5%. The increasing preference for self-injection devices market is driving the injectable drug delivery devices market. Self-injection devices are medical devices that can be used by the patient in-home setting for self-administration of the medication. Self-injection devices include needle-free, auto, pen, and wearable injectors. These self-injectables were developed to provide the most adaptable device which has a high precision of drug delivery and is easy to use. In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years. BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson, and Company, which is clinically proven, reliable, and cost-effective specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. The other companies currently involved in the self-injections market include Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period. Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi. The emergence of alternative drug delivery devices to injectable drug delivery devices market is negatively affecting the market. Injectable (parenteral) drug delivery is one of the widely used conventional drug delivery systems. There are many alternative (painless) drug delivery systems such as nasal, transdermal, transmucosal, vaginal, anal, and others that are evolving. The selection of a drug delivery system depends on the drug release, absorption, distribution, metabolism, and elimination profile of the therapeutic agent to achieve the highest level of safety and efficacy from the drug. Alternative drug delivery systems hold key importance in improving bioavailability, reducing toxicity, and safety elimination of drug which is administered to treat a particular disease. Growing disease-related complications, regular developments in drugs, and combinations of therapeutic agents are used to treat disease driving the need for alternative drug delivery systems. There are some recent ongoing developments in the field of alternative drug delivery systems mainly in a nanoparticles-based delivery system, intracellular delivery system, neural delivery system, and many more. Thus, the emergence of alternative drug delivery methods limits the growth of the injectable drug delivery devices market. The companies in injectable drug delivery devices market are increasingly focusing on the manufacturing of auto-injectors. The auto-injectors are fully automated, highly customized, and reusable injectors that can be used by a patient to perform hundreds of injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during injection. These devices can adjust the speed and depth of the automatic injection. For instance, LISA, a reusable auto-injector manufactured by Unilife corporation comes with an array of highly customizable features including Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming for target therapies. The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches to improve the convenience and ease of administration of parenteral therapeutics. North America was the largest region in the injectable drug delivery devices market in 2022. Western Europe was the second-largest region in the injectable drug delivery devices market report. The regions in the injectable drug delivery devices industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries included in the injectable drug delivery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with a injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Nebulizers Market Definition

Orthopedic braces and support devices and equipment are primarily used in injury prevention, injury rehabilitation, post-operative care, and osteoarthritic care. The main types of orthopedic braces and support devices and equipment market are lower extremity braces, upper extremity braces, back, and hip braces, and other braces. Lower extremity braces are the braces that are used to support the ankle, foot, knee, and hip and are used in various applications. The various products are soft and elastic braces and supports, hinged braces and supports, and hard and rigid braces and support that are used by hospitals, home healthcare, clinics, and other end-users. The global orthopedic braces and support devices and equipment market is segmented - 1) By Type: Lower extremity braces, Upper extremity braces, Back and hip braces, Other braces 2) By End User: Hospitals, Home Healthcare, Clinics, Other End-Users 3) By Product: Soft & Elastic Braces and Supports, Hinged Braces and Supports, Hard & Rigid Braces and Supports The global orthopedic braces and support devices and equipment market size will grow from $3.86 billion in 2022 to $4.08 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global orthopedic braces and support devices and equipment is expected to grow to $4.98 billion in 2027 at a CAGR of 5.1%. The rise in the geriatric population is driving the orthopedic braces and support devices and equipment market. Elderly people are more prone to injuries as their bones and connective tissues weaken with age. For example, In the US 70% of the population aged between 50-70 years suffers from osteoarthritis and is likely to increase further in the forecast period. This is one of the major contributing factors to the growth of this market. High adoption of pain medications worldwide restraints the growth of the orthopedic braces and support devices market. As more amount of people relies on pain killers for pains related to orthopedic disorders instead of adopting the use of a proper support device/braces. For example, Americans consume 80% of the world's supply of painkillers including painkillers for orthopedic treatments, thereby, hindering the orthopedic braces and support devices and equipment market. Major players in the orthopedic braces and support devices and equipment market are DJO Global, Bauerfeind AG, Otto Bock Healthcare GmbH, Breg, Inc., Ossur Hf, DeRoyal Industries, Inc., BSN Medical, Medi GmbH & Co. KG, THUASNE Group, 3M Company, and Lohmann & Rauscher. Due to the increase in the demand for orthopedic braces and support devices and equipment, various companies are adapting themselves to use innovative technologies such as bionic energy savers to solve problems related to injuries in the knee, arms, or any other movable part of the body. For example, spring-loaded technology uses LevitationTM bionic knee brace that enhances mobility and provides strength to legs by storing energy when a person sits or rests. These technologies are providing a better quality of life to people and positively impact the growth of the market. 3M’s consumer health care division issued orders to recall ankle braces and supports as the product contained undeclared natural latex rubber which may lead to allergic reactions in a few users. FDA ranked the recall as Class 2, which are labeled as products causing a temporary health issue or pose a risk of minimal adversity. Thus, any product recall may hamper the market’s growth as it would create negative feedback regarding the product and people would hesitate to use the products. In April 2021, DJO, a global leader in braces and support devices acquired Medshape Inc. for an undisclosed amount. This acquisition, the portfolio includes innovative devices for, joint fusion, fracture fixation, and soft tissue injury repair that utilize biomaterial technologies designed to improve patient outcomes. Medshape Inc., a company operating in orthopedic braces and support devices market-based in Georgia. [xii] North America was the largest region in global orthopedic braces and support devices and equipment market in 2022. Western Europe was the second-largest region in the orthopedic braces and support devices and equipment market report. The regions covered in the orthopedic braces and support devices and equipment analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic braces and support devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, USA, and Australia. The orthopedic braces and support devices and equipment market consist of sales of soft & elastic braces and supports, hard braces and supports, and hinged braces and supports. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic braces and support devices and equipment market research report is one of a series of new reports from The Business Research Company that provides orthopedic braces and support devices and equipment market statistics, including orthopedic braces and support devices and equipment industry global market size, regional shares, competitors with a orthopedic braces and support devices and equipment market share, detailed orthopedic braces and support devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic braces and support devices and equipment industry. This orthopedic braces and support devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical tourism is the process of travelling to another country solely for the reasons of medical treatment. It is useful for people living in countries where appropriate medical facilities are not available. The main types of medical tourism are domestic and international. Domestic health or medical tourism is when a person travels from his or her regular place of residence to another inside the state in order to receive better medical treatment or because the therapy available in his or her usual place of residence is too expensive. The different treatment types include cosmetic treatment, dental treatment, cardiovascular treatment, orthopedics treatment, bariatric treatment, fertility treatment, opthalmic treatment, others and involves various service providers such as public, private. The several healthcare services include medical treatment, wellness, alternative treatment. The global medical tourism market is segmented - 1) By Treatment Type: Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedics Treatment, Bariatric Treatment, Fertility Treatment, Opthalmic Treatment, Other Treatments 2) By Type: Domestic, International 3) By Healthcare Service: Medical Treatment, Wellness, Alternative Treatment 4) By Service Providers: Public, Private The global medical tourism market size will grow from $35.77 billion in 2022 to $39.95 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global medical tourism is expected to grow to $59.67 billion in 2027 at a CAGR of 10.5%. High healthcare cost in developed countries is driving growth in the medical tourism market as developing countries are able to provide cheaper treatment. Patients usually travel to developing countries with quality healthcare infrastructure and low healthcare costs. According to a study conducted by the Centres for Disease Control and Prevention, approximately 0.75 -1.6 million people from the USA travel out of the country for medical care to avoid high treatment cost. For instance, a hip replacement surgery in the USA costs approximately $39,299 while the same surgery in India, Costa Rica or other developing countries would cost between $7000 and $15,000 including logistics. Major players in the medical tourism market report are Apollo Hospital Enterprise Limited, Prince Court Medical Centre, Bumrungrad International Hospital, KPJ Healthcare Berhad, Fortis Health Ltd., Raffles Medical Group, Bangkok Hospital Medical Centre, Samitivej PCL., Min-Sheng General Hospital and Asian Heart Institute. The coronavirus disease (COVID-19) outbreak is to act as a major restraint for the growth of the medical tourism industry during 2020 and 2021. According to the World Health Organization’s report, 213 countries are affected by the COVID-19 outbreak including countries with a high number of medical tourists such as the USA, China, Japan, and South Korea. The government of various countries has banned travellers from affected countries, barred flights to certain countries, and changed the visa requirements. The American Centres for Disease Control and Prevention (CDC) predicted that the situation could last into 2021 and is likely to impact the medical tourism industry significantly. Therefore, the coronavirus outbreak and travel bans are expected to restrict the growth of the industry in the near future. Patients traveling across countries for medical treatment are increasingly using electronic health records to store information related to health in digital format. An electronic health record is the systematic collection of patient health and medical examination reports stored electronically. These health records can be accessed instantly and securely by authorized users. Electronic health records eliminate the need to carry heavy medical records for patients travelling long distances for treatment. Some of the major electronic health records software include eClinicalWorks, Allscripts, Cerner. In September 2020, IHH Healthcare, a Malaysian–Singaporean private healthcare group focused on upmarket health services acquired Prince Court Medical Centre for $0.25 billion. Through this acquisition, Prince Court Medical Centre will complement IHH's cluster strategy of having specialized tertiary hospitals in Kuala Lumpur. Prince Court Medical Centre is a private healthcare facility located in the heart of Kuala Lumpur, Malaysia. North America was the largest region in the medical tourism market in 2022. Western Europe was the second largest region in the global medical tourism market share. The regions covered in the medical tourism market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical tourism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical tourism market includes revenues earned by entites by providing inbound medical tourism services, and outbound medical tourism services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.It does not include revenues from resales either further along the supply chain or as part of other products. The medical tourism market research report is one of a series of new reports from The Business Research Company that provides medical tourism market statistics, including medical tourism industry global market size, regional shares, competitors with a medical tourism market share, detailed medical tourism market segments, market trends and opportunities, and any further data you may need to thrive in the medical tourism industry. This medical tourism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.